| Patents for A61P 27 - Drugs for disorders of the senses (53,017) |
|---|
| 09/24/2009 | WO2009116524A1 Modified protein |
| 09/24/2009 | WO2009116490A1 Remedy for meniere's disease |
| 09/24/2009 | WO2009115023A1 A anthocyanins phospholipid complex and the preparative method thereof |
| 09/24/2009 | WO2009063081A3 Composition comprising at least one nucleosidic moiety as a therapeutic agent, and ckc. |
| 09/24/2009 | US20090239954 Phosphate buffered ophthalmic solutions displaying improved efficacy |
| 09/24/2009 | US20090239947 Inhibition of proliferation and fibrotic response of activated corneal stromal cells |
| 09/24/2009 | US20090239864 6- (pyridinyl) -4-pyrimidone derivates as tau protein kinase 1 inhibitors |
| 09/24/2009 | US20090239842 Solutions containing epinastin |
| 09/24/2009 | US20090239833 Enhancement of activity and/or duration of action of soft anti-inflammatory steroids for topical or other local application |
| 09/24/2009 | US20090239805 Human 3 relaxin |
| 09/24/2009 | US20090239801 Modified Fusion Polypeptides |
| 09/24/2009 | US20090238858 Compositions and Methods for Treating Ophthalmic Diseases |
| 09/24/2009 | US20090238800 Isolation and therapeutic application of adult retinal stem cells collected from extra-retinal tissues |
| 09/24/2009 | CA2719134A1 Treatment with opioid antagonists and mtor inhibitors |
| 09/24/2009 | CA2718713A1 Therapeutic compounds |
| 09/24/2009 | CA2717679A1 Aqueous pharmaceutical compositions containing borate-polyol complexes |
| 09/23/2009 | EP2103607A1 1-phenyl 1-thio-d-glucitol derivative |
| 09/23/2009 | EP2101725A1 Use of l-carnitine or of alkanoyl l-carnitines for the preparation of a physiological supplement or medicament for ophthalmic use in the form of eye drops |
| 09/23/2009 | EP1799204B1 Composition containing omega-3 fatty acids and omega-6 fatty acids |
| 09/23/2009 | EP1478662B1 Method for producing hypoallergenic major birch pollen allergens rbet v 1 |
| 09/23/2009 | EP1461038B9 Arylsulfonamide derivatives for use as ccr3 antagonists in the treatment of inflammatory and immunological disorders |
| 09/23/2009 | EP1435935B1 Concentrated x-ray contrast media can act as universal antigens and can inhibit or prevent allergic reactions |
| 09/23/2009 | EP1339418B1 Improved ophthalmic and contact lens solutions containing simple saccharides as preservative enhancers |
| 09/23/2009 | EP1282684B1 Chondroitin synthase gene and methods of making and using same |
| 09/23/2009 | CN101538254A Derivatives of 1-piperazine- and 1-homopiperazine-carboxylates, preparation method thereof and use of same as inhibitors of the faah enzyme |
| 09/23/2009 | CN101538244A 1h-imidazole derivatives having cb1 agonistic, cb1 partial agonistic or cb1- antagonistic activity |
| 09/23/2009 | CN101537182A Combination comprising an HMG CoA reductase inhibitor and an insulin secretor enhancer or an insulin sensitizer |
| 09/23/2009 | CN101537172A Recombinant human keratinocyte growth factor-2 containing eye drops and method for preparing same |
| 09/23/2009 | CN101537087A Traditional Chinese medicine composition for treating retinal vein obstruction |
| 09/23/2009 | CN101537077A Chinese medicinal mixed tincture |
| 09/23/2009 | CN101537019A Medicine for curing tympanitis |
| 09/23/2009 | CN101537010A Eyedrop preparation and preparation method thereof |
| 09/23/2009 | CN101536974A Eye methazolamide temperature-sensitive situ-gel preparation and preparation method thereof |
| 09/22/2009 | US7592455 potent and selective inhibitors of p38 kinase, especially p38 alpha , p38 beta and p38 beta 2; immune or inflammatory disorders; Ethyl 3-(benzylamino)-6-oxo-7-phenyl-6,7-dihydrothieno[2,3-b]pyridine-2-carboxylate |
| 09/22/2009 | US7592450 used to inhibit proliferative conditions, such as cancer and psoriasis, with improved bioavailability and stability |
| 09/22/2009 | US7591949 Method for the improvement of transport across adaptable semi-permeable barriers |
| 09/22/2009 | CA2402121C Method for increasing intestinal absorption of fat soluble vitamins in post-menopausal women and lower animals |
| 09/22/2009 | CA2399451C Tyrosine derivatives with anti-leukotriene activity |
| 09/22/2009 | CA2396720C Thiazolyl amide derivatives |
| 09/17/2009 | WO2009114878A2 Methods and compositions for genetic and retinal disease |
| 09/17/2009 | WO2009114744A1 Therapeutic compounds |
| 09/17/2009 | WO2009114623A2 Angiostatic compositions comprising truncated tyrosyl-trna synthetase polypeptides and methods of using same |
| 09/17/2009 | WO2009114521A1 Low viscosity, highly flocculated triamcinolone acetonide suspensions for intravitreal injection |
| 09/17/2009 | WO2009114373A1 Treatment for ocular-related disorders |
| 09/17/2009 | WO2009113743A1 Polyethylene glycolated lactoferrin complex and method of producing the same |
| 09/17/2009 | WO2009113320A1 Mmp inhibitor |
| 09/17/2009 | WO2009112878A1 Drug delivery to the anterior and posterior segments of the eye using eye drops. |
| 09/17/2009 | WO2009112758A2 Novel use of zinc n-acetyltaurinate |
| 09/17/2009 | WO2009112691A2 Derivatives of tetrahydroquinoxaline urea, preparation thereof and therapeutic application thereof |
| 09/17/2009 | WO2009111838A1 Method of treatment using antimicrobial composition |
| 09/17/2009 | WO2009084069A3 Ocular solution with organic lycopene |
| 09/17/2009 | WO2009051670A3 Oxylipin compounds for the treatment of ophthalmic conditions |
| 09/17/2009 | US20090234004 Pharmaceutical compositions having desirable bioavailability |
| 09/17/2009 | US20090233980 Substituted gamma lactams as therapeutic agents |
| 09/17/2009 | US20090233974 Substituted gamma lactams as therapeutic agents |
| 09/17/2009 | US20090233890 Low viscosity, highly flocculated triamcinolone acetonide suspensions for intravitreal injection |
| 09/17/2009 | US20090233867 Treatment of ocular wounds and ulcers |
| 09/17/2009 | US20090233813 Condensed Heterocyclic Pyrazole Derivatives as Kinase Inhibitors |
| 09/17/2009 | US20090232803 Antibodies to human il-1beta |
| 09/17/2009 | US20090232779 Oligodendrocytes derived from human embryonic stem cells for remyelination and treatment of spinal cord injury |
| 09/17/2009 | US20090232772 Human corneal endothelial cell-derived precursor cells, cellular aggregates, methods for manufacturing the same, and methods for transplanting precursor cells and cellular aggregates |
| 09/17/2009 | US20090232763 Aqueous pharmaceutical compositions containing borate-polyol complexes |
| 09/17/2009 | CA2718237A1 Method of treatment using antimicrobial composition |
| 09/17/2009 | CA2718161A1 Drug delivery to the anterior and posterior segments of the eye using eye drops |
| 09/17/2009 | CA2718153A1 Angiostatic compositions comprising truncated tyrosyl-trna synthetase polypeptides and methods of using same |
| 09/17/2009 | CA2717991A1 Treatment for ocular-related disorders |
| 09/17/2009 | CA2716764A1 Novel use of zinc n-acetyltaurinate |
| 09/17/2009 | CA2713367A1 Derivatives of tetrahydroquinoxaline urea, preparation thereof and therapeutic application thereof |
| 09/16/2009 | EP2100876A2 New compounds for the inhibition of rotamases and use thereof |
| 09/16/2009 | EP1605847B1 Antibody-targeted photodynamic therapy |
| 09/16/2009 | EP1523471B1 Urea-substituted and urethane-substituted acylureas, methods for the production thereof and their use as medicaments |
| 09/16/2009 | EP1478656B1 Oligonucleotide compositions with enhanced efficiency |
| 09/16/2009 | EP1438583B1 Measuring circulating therapeutic antibody, antigen and antigen/antibody complexes using elisa assays |
| 09/16/2009 | EP1419149B1 Benzo[g]quinoline derivatives for treating glaucoma and myopia |
| 09/16/2009 | EP1414825B9 Thienopyrimidinediones and their use in the modulation of autoimmune disease |
| 09/16/2009 | EP1283834B1 Inhibitors of 11-beta-hydroxy steroid dehydrogenase type 1 |
| 09/16/2009 | CN101531715A Cytokine protein family |
| 09/16/2009 | CN101531704A Peptide-based compounds |
| 09/16/2009 | CN101530621A Oxidation resisting dipeptide medicament intercalated houghite and preparation method thereof |
| 09/16/2009 | CN101530520A Deflocculat suppository powder |
| 09/16/2009 | CN101530502A Traditional Chinese medicine for treating diabetic fundus hemorrhage |
| 09/16/2009 | CN101530491A Method of preparing gardenia extract by applying membrane filtration technology |
| 09/16/2009 | CN101530489A Chinese medicine composition used for treating non-active stage infiltrative exophthalmos of thyroid-associated ophthalmopathy and preparation method thereof |
| 09/16/2009 | CN101530430A Nanometer earthworm oral preparation and preparation method thereof |
| 09/16/2009 | CN100540570C Devivatives of partially desulphated glycosaminoglycans endowed with antiangiogenic activity and devoid of anticoagulating effect |
| 09/15/2009 | US7589200 5-Fluoro-4N-phenyl-4-pyrimidineamine compounds |
| 09/15/2009 | US7589125 2-acetoxy-4-(2,2,3,3,3-pentafluoropropoxy)benzoic acid; methyl 2-hydroxy-4-(2,2,3,3,3-pentafluoropropoxy)benzoate; psoriasis and other immune diseases |
| 09/15/2009 | US7589091 2(R)-Benzyloxymethyl-4-[4-(4-chloro-phenyl)-piperazin-1-yl]-N-hydroxy-3(S)-(4-methoxy-phenyl)-4-oxo-butyramide; inhibiting matrix metalloproteinase; immunosuppression; neuropathic pain |
| 09/15/2009 | US7588761 Antibody for use in the treatment and prevention of sepsis, infections, autoimmune and graft-versus-host diseases; biodegradable, biocompatible polymer and human antibody, or an antigen-binding portion thereof, that dissociates from human TNF alpha |
| 09/15/2009 | US7588760 Binds to a denatured collagens but not to native triple helical forms of the collagen; antitumor agents, antimetastasis agents; monoclonal antibodies; drug screening for denatured collagen antagonists |
| 09/15/2009 | CA2532596C Anti-inflammatory formulations |
| 09/15/2009 | CA2359463C Novel polyhydroxypyrazine derivatives, preparation and pharmaceutical compositions containing same |
| 09/15/2009 | CA2342985C Hydroxamate-containing cysteine and serine protease inhibitors |
| 09/15/2009 | CA2218699C 1,3-propane diol derivatives as bioactive compounds |
| 09/11/2009 | WO2009111603A2 Deitary supplement for eye health |
| 09/11/2009 | WO2009111417A1 Substituted beta-lactams |
| 09/11/2009 | WO2009111322A1 Substituted cyclopentanes having prostaglandin activity |
| 09/11/2009 | WO2009110526A1 Prophylactic or therapeutic agent for optic nerve disorders comprising 3',5-di-2-propenyl-(1,1'-biphenyl)-2,4'-diol as active ingredient |
| 09/11/2009 | WO2009110519A1 Novel 1-aminocarbonylpiperidine derivative |
| 09/11/2009 | WO2009109501A2 Ocular pharmaceutical compositions |